Precision BioSciences
DTIL
DTIL
118 hedge funds and large institutions have $231M invested in Precision BioSciences in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.14% more ownership
Funds ownership: 1.63% → 1.76% (+0.14%)
4% less call options, than puts
Call options by funds: $1.39M | Put options by funds: $1.44M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
118
Holding in Top 10
2
Calls
$1.39M
Puts
$1.44M
Top Buyers
| 1 | +$15.1M | |
| 2 | +$12.1M | |
| 3 | +$3.65M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.78M |
| 5 |
BlackRock
New York
|
+$2.23M |
Top Sellers
| 1 | -$8M | |
| 2 | -$1.64M | |
| 3 | -$1.57M | |
| 4 |
CA
CHI Advisors
New York
|
-$1.36M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$1.33M |